Since belinostat used at cytostatic concentration increased the expression of Bim and Puma while partially repressing that of Bcl‐xL, we hypothesized that combining it with strategies inhibiting residual Bcl‐xL or Mcl‐1 proteins might be effective in inducing apoptosis in ovarian cancer cells. This evidence concerns the gene BCL2L1 and ovarian cancer.